Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:RP)

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire November 28, 2023

RepliCel Provides Corporate Update

Accesswire November 28, 2022

RepliCel (TSXV:RP) extends warrant expiry

Caroline Egan  September 16, 2022

RepliCel Announces Material Patent Milestones in Key Markets

Accesswire August 4, 2022

DermaPrecise(TM) Injection System Shown to Produce Consistently High Cell Count and Viability for Cell Therapy Injections

Accesswire August 2, 2022

RepliCel's Manufacturing Inspected by Japan's PMDA

Accesswire July 28, 2022

CORRECTION: Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing

Accesswire July 26, 2022

Independent Laboratory Test Results Confirm Value of DermaPrecise (TM) Injection Consistency in Clinical Simulation Testing

Accesswire July 26, 2022

RepliCel Announces Material Patent Milestones

Accesswire January 10, 2022
View More News ››

Opinion & Analysis (TSXV:RP)

Groundbreaking Biotech Company Takes Major Step Forward with Deal with Chinese Partner

Streetwise Reports October 18, 2018

Cell Therapy Company and Chinese Firm Sign Marketing Deal

Streetwise Reports July 16, 2018

Cell Therapy Firm Finalizing $5.1M Strategic Investment and Partnership with Chinese Company

Streetwise Reports May 9, 2018

Regenerative medicine company's China deal is 'dramatically transformational'

Streetwise Reports January 19, 2018

Japan is fertile ground for biotech deals

The Life Sciences Report October 4, 2017

String of positive trial results boosts RepliCel's profile

The Life Sciences Report April 13, 2017
View More Opinion ››

Bullboard Posts (TSXV:RP)

What is the Plan

Andrew Schutte will be loaning "up to $1,000,000 contingent on acquiring all assets of Replicel. From today's NR: "The...
Ingiboy - 5 days ago

RE:RE:Highway robbery

I get the impression that this move is designed to protect one person's interest if we vote NO and the Company ultimately goes...
RPINVESTOR1 - 5 days ago

RE:Highway robbery

2nd try at pasting... Mr. Andrew Schutte reports REPLICEL ANNOUNCES SECURED LOAN AGREEMENT RepliCel Life Sciences Inc. has...
lscfa - 5 days ago

Highway robbery

RepliCel Announces Secured Loan Agreement   VANCOUVER, BC, CANADA –April 17, 2024 – RepliCel Life Sciences Inc. (OTCPK: REPCF) ...
lscfa - 5 days ago

RE:RE:RE:RE:RE:RE:NEW TRANSFER AGENT AS OF APRIL 11, 2024.

RPINVESTOR - Thank You!!
MetzGER - 13 days ago

RE:RE:RE:RE:RE:NEW TRANSFER AGENT AS OF APRIL 11, 2024.

MetzGER:- Ok.
RPINVESTOR1 - 13 days ago
View more Bullboard ››

Mullen Group Ltd.

Mullen Group Ltd.

Mullen Group is one of North America's largest logistics providers with a network of independently operated businesses ...
View More »